Publicaciones en colaboración con investigadores/as de Clínica Universitaria de Navarra (23)

2024

  1. Cardiometabolic risk stratification using a novel obesity phenotyping system based on body adiposity and waist circumference

    European Journal of Internal Medicine, Vol. 124, pp. 54-60

2020

  1. Impact of Routine and Long-Term Follow-Up on Weight Loss after Bariatric Surgery

    Obesity Surgery, Vol. 30, Núm. 11, pp. 4293-4299

2018

  1. High Body Adiposity Drives Glucose Intolerance and Increases Cardiovascular Risk in Normoglycemic Subjects

    Obesity, Vol. 26, Núm. 4, pp. 672-682

2016

  1. Does Preincisional Infiltration with Bupivacaine Reduce Postoperative Pain in Laparoscopic Bariatric Surgery?

    Obesity Surgery, Vol. 26, Núm. 2, pp. 282-288

2012

  1. Small-bowel migration: A possible complication of adjustable intragastric balloons

    Endoscopy

2011

  1. Association of increased Visfatin/PBEF/NAMPT circulating concentrations and gene expression levels in peripheral blood cells with lipid metabolism and fatty liver in human morbid obesity

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 21, Núm. 4, pp. 245-253

2010

  1. Involvement of serum vascular endothelial growth factor family members in the development of obesity in mice and humans

    Journal of Nutritional Biochemistry, Vol. 21, Núm. 8, pp. 774-780

2009

  1. Acylated and desacyl ghrelin stimulate lipid accumulation in human visceral adipocytes

    International Journal of Obesity, Vol. 33, Núm. 5, pp. 541-552

  2. Increased adipose tissue expression of lipocalin-2 in obesity is related to inflammation and matrix metalloproteinase-2 and metalloproteinase-9 activities in humans

    Journal of Molecular Medicine, Vol. 87, Núm. 8, pp. 803-813

  3. RIP140 gene and protein expression levels are downregulated in visceral adipose tissue in human morbid obesity

    Obesity Surgery, Vol. 19, Núm. 6, pp. 771-776

2008

  1. Expression of caveolin-1 in human adipose tissue is upregulated in obesity and obesity-associated type 2 diabetes mellitus and related to inflammation

    Clinical Endocrinology, Vol. 68, Núm. 2, pp. 213-219

  2. Influence of morbid obesity and insulin resistance on gene expression levels of AQP7 in visceral adipose tissue and AQP9 in liver

    Obesity Surgery, Vol. 18, Núm. 6, pp. 695-701

  3. Obesidad abdominal: Un estandarte del riesgo cardiometabólico

    Endocrinologia y Nutricion, Vol. 55, Núm. 9, pp. 420-432

  4. Serum retinol-binding protein 4 is not increased in obesity or obesity-associated type 2 diabetes mellitus, but is reduced after relevant reductions in body fat following gastric bypass

    Clinical Endocrinology, Vol. 69, Núm. 2, pp. 208-215

2007

  1. Influence of waist circumference on the metabolic risk associated with impaired fasting glucose: Effect of weight loss after gastric bypass

    Obesity Surgery, Vol. 17, Núm. 5, pp. 585-591

  2. Plasma osteopontin levels and expression in adipose tissue are increased in obesity

    Journal of Clinical Endocrinology and Metabolism, Vol. 92, Núm. 9, pp. 3719-3727

  3. Proinflammatory cytokines in obesity: Impact of type 2 diabetes mellitus and gastric bypass

    Obesity Surgery, Vol. 17, Núm. 11, pp. 1464-1474

  4. The obestatin receptor (GPR39) is expressed in human adipose tissue and is down-regulated in obesity-associated type 2 diabetes mellitus

    Clinical Endocrinology, Vol. 66, Núm. 4, pp. 598-601

  5. Validation of endogenous control genes in human adipose tissue: Relevance to obesity and obesity-associated type 2 diabetes mellitus

    Hormone and Metabolic Research, Vol. 39, Núm. 7, pp. 495-500

2006

  1. Increased cardiovascular risk markers in obesity are associated with body adiposity: Role of leptin

    Thrombosis and Haemostasis, Vol. 95, Núm. 6, pp. 991-996